Table 2.
Nonatherosclerotic angiopathies | Cervicocephalic arterial dissection |
Cerebral amyloid angiopathy | |
Moyamoya disease | |
Fibromuscular dysplasia | |
Reversible cerebral vasoconstriction syndrome | |
Susac’s syndrome | |
Sneddon’s syndrome | |
Migraine-induced stroke | |
Hematologic conditions | Hypercoagulable state due to deficiencies of protein S, protein C, or antithrombin; factor V Leiden mutation, prothrombin gene G20210A mutation |
Acquired hypercoagulable state (eg, cancer, pregnancy, hormonal contraceptive use, exposure to hormonal treatments such as anabolic steroids and erythropoietin, nephrotic syndrome) | |
Antiphospholipid syndrome | |
Hyperhomocysteinemia | |
Sickle cell disease | |
Myeloproliferative disorders (eg, leukemia, lymphoma) | |
Genetic | Fabry disease |
CADASIL | |
MELAS | |
Marfan syndrome | |
Neurofibromatosis | |
Sturge-Weber disease | |
Inflammatory and infectious | Vasculitis (primary angiitis of the CNS, Sjögren syndrome, Wegener’s granulomatosis) |
Temporal arteritis | |
Takayasu disease | |
Behçet’s syndrome | |
Neurosarcoidosis | |
Neurocysticercosis | |
HIV | |
Varicella zoster virus | |
Neurosyphilis | |
Tuberculous meningitis |
Abbreviations: CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CNS, central nervous system; HIV, human immunodeficiency virus; MELAS, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes.